College of Osteopathic Medicine

Search results

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $36.66) shares post best week in four weeks; +40c [1.1%]

  Thomas, M.

  28/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.11) down 3.3% in 2 weeks; -59c [2.0%]

  Thomas, M.

  28/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.70) decreases 1.3% on firm volume; -39c [1.3%] Vol Index 1.3 [1 is avg]

  Thomas, M.

  21/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $36.26) keeps sliding: down 21% in 3 weeks; -$2.21 [5.7%] Vol Index 1.4 [1 is avg]

  Thomas, M.

  21/12/24

  1 item of Media coverage

  Press/Media

• Okla. Gov. Stitt Appoints Jennifer Austin as District Attorney for District 21

  Austin, J.

  20/12/24

  1 item of Media coverage

  Press/Media

• OSU-COM students make impact on Latinx youth with Schweitzer Fellowship

  Delgado, P.

  18/12/24

  1 item of Media coverage

  Press/Media

• OSU-COM Students Make Impact on Latinx Youth With Schweitzer Fellowship

  Delgado, P.

  18/12/24

  1 item of Media coverage

  Press/Media

• OSU-COM STUDENTS MAKE IMPACT ON LATINX YOUTH WITH SCHWEITZER FELLOWSHIP

  Delgado, P.

  17/12/24

  1 item of Media coverage

  Press/Media

• OSU-COM STUDENTS MAKE IMPACT ON LATINX YOUTH WITH SCHWEITZER FELLOWSHIP

  Delgado, P.

  17/12/24

  1 item of Media coverage

  Press/Media

• Artist Katina Bitsicas tells the story of grief and loss to help everyone deal with it

  Johnson, A.

  17/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $38.47) in bottom 1% performers of NYSE market in past week; -$6.33 [14.1%]

  Thomas, M.

  14/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $30.23) increases 0.9% on average volume; +26c [0.9%]

  Thomas, M.

  14/12/24

  1 item of Media coverage

  Press/Media

• Data on Cancer Reported by Researchers at Oklahoma State University Center for Health Sciences (Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials)

  Vassar, M., Johnson, B. & Hughes, G.

  13/12/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding decreases 6.2% in 2024

  Thomas, M.

  13/12/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical decreases 2.2% in 2024

  Thomas, M.

  13/12/24

  1 item of Media coverage

  Press/Media

• Reports from Oklahoma State University Center for Health Sciences Add New Data to Research in Lung Cancer (Assessing the Uptake of the Lung Cancer Core Outcome Set: A Cross-Sectional Analysis)

  Vassar, M., Ford, A. & Hughes, G.

  11/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.97) decreases 1.7% on weak volume; -53c [1.7%]

  Thomas, M.

  7/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $44.80) drops 2.6% on weak volume; -$1.21 [2.6%]

  Thomas, M.

  7/12/24

  1 item of Media coverage

  Press/Media

• OSU/A&M Regents approve personnel actions

  Hanson, C.

  6/12/24

  1 item of Media coverage

  Press/Media

• OSU/A&M REGENTS APPROVE PERSONNEL ACTIONSNEW APPOINTMENTSCHANGES IN APPOINTMENT

  Hanson, C.

  6/12/24

  1 item of Media coverage

  Press/Media

• Winners Announced for 2024 OSU App Competition

  Morris, A.

  5/12/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding increases 7.5% in 2024

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding advances 47% in past year

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media

• Winners announced for 2024 OSU App Competition

  Morris, A.

  3/12/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical adds 20% in past year

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media